Tweet
<img alt="" height="1" width="1" />
HDL Booster Improves Glycemic Control
MedPage Today
Explain that a posthoc analysis of the ILLUMINATE trial found that torcetrapib plus atorvastatin lowered plasma glucose, insulin, and hemoglobin A1c when compared with atorvastatin alone. ...
Controversial Cholesterol Drug Might Lower Blood Sugar Levels in DiabeticsU.S. News & World Report
Torcetrapib raised HDL, may help control diabetesEndocrine Today
Study Suggests Possibility that CETP Inhibitors May Improve Glycemic ControlForbes (blog)
TheHeart.Org
all 7 news articles »
More...